Researchers utilize a biomarker to predict disease severity during early stages of pneumonia.
Michael Brady, MD, an Infectious Diseases specialist at Nationwide Children’s Hospital, answers this common question from primary care providers.
Stewards thread together monitoring programs and new protocols while trimming unwarranted tests and diagnostic speed.
For decades, complete blood cell counts have been the go-to way to identify babies at high risk for serious bacterial infections. But recent research shows the popular lab test isn’t as useful as everyone thought.
If asthma development in people parallels mice, the cells’ mechanisms may provide a target for disease prevention.
With the recent publication of two papers, researchers shed light on factors that influence disease severity and immune response to respiratory syncytial virus infection in infants and young children.
